James D. Neaton

53.5k total citations · 15 hit papers
232 papers, 32.3k citations indexed

About

James D. Neaton is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Emergency Medicine. According to data from OpenAlex, James D. Neaton has authored 232 papers receiving a total of 32.3k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Infectious Diseases, 61 papers in Cardiology and Cardiovascular Medicine and 55 papers in Emergency Medicine. Recurrent topics in James D. Neaton's work include HIV-related health complications and treatments (54 papers), HIV/AIDS Research and Interventions (49 papers) and HIV Research and Treatment (48 papers). James D. Neaton is often cited by papers focused on HIV-related health complications and treatments (54 papers), HIV/AIDS Research and Interventions (49 papers) and HIV Research and Treatment (48 papers). James D. Neaton collaborates with scholars based in United States, United Kingdom and Australia. James D. Neaton's co-authors include Deborah Wentworth, Jeremiah Stamler, Olga Vaccaro, David R. Jacobs, Lewis H. Kuller, Felipe A. Martínez, Barbara Roniker, Richard M. Bittman, Jay H. Kleiman and Marjorie Gatlin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

James D. Neaton

231 papers receiving 30.8k citations

Hit Papers

Eplerenone, a Selective Aldosterone Blocker, in Patien... 1989 2026 2001 2013 2003 1993 1989 2000 1996 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
    2003 3.4k citations Faı̈ez Zannad, James D. Neaton et al. profile →
  2. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial
    1993 3.1k citations Jeremiah Stamler, James D. Neaton et al. profile →
  3. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
    1989 2.5k citations James D. Neaton et al. Circulation profile →
  4. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II
    2000 1.3k citations Philip A. Poole‐Wilson, Kenneth Dickstein et al. profile →
  5. Blood Pressure and End-Stage Renal Disease in Men
    1996 1.2k citations Paul K. Whelton, Bryan Randall et al. profile →
  6. Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
    2008 1.2k citations Lewis H. Kuller, Russell P. Tracy et al. PLoS Medicine profile →
  7. The Prevention and Treatment of Missing Data in Clinical Trials
    2012 1.2k citations James D. Neaton et al. profile →
  8. Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
    2011 856 citations Netanya G. Sandler, Handan Wand et al. The Journal of Infectious Diseases profile →
  9. Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention Trial
    1989 844 citations Deborah Wentworth, James D. Neaton et al. profile →
  10. Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
    2010 660 citations Jacqueline Neuhaus, Jason V. Baker et al. The Journal of Infectious Diseases profile →
  11. Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men
    1992 618 citations James D. Neaton profile →
  12. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group
    1992 554 citations James D. Neaton profile →
  13. EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION
    2003 539 citations James D. Neaton, Felipe A. Martínez et al. profile →
  14. Report of the Conference on Low Blood Cholesterol: Mortality Associations.
    1992 521 citations James D. Neaton et al. Circulation profile →
  15. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
    2009 436 citations Marvin A. Konstam, James D. Neaton et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James D. Neaton United States 77 12.8k 9.0k 6.2k 4.4k 4.1k 232 32.3k
Michael G. Shlipak United States 93 10.7k 0.8× 2.9k 0.3× 4.2k 0.7× 2.4k 0.6× 3.5k 0.8× 544 33.0k
Alan S. Go United States 93 25.3k 2.0× 3.6k 0.4× 5.6k 0.9× 1.0k 0.2× 1.3k 0.3× 483 47.4k
James B. Meigs United States 111 9.4k 0.7× 15.0k 1.7× 5.3k 0.9× 1.1k 0.2× 1.4k 0.3× 400 44.5k
Patrick E. McBride United States 37 12.5k 1.0× 7.8k 0.9× 10.5k 1.7× 625 0.1× 1.3k 0.3× 119 29.9k
Alastair J.J. Wood United States 82 4.8k 0.4× 2.2k 0.2× 4.4k 0.7× 2.0k 0.5× 720 0.2× 227 25.8k
Neil J. Stone United States 49 15.3k 1.2× 14.3k 1.6× 18.9k 3.0× 612 0.1× 1.2k 0.3× 191 45.2k
Lesley A. Stevens United States 45 9.8k 0.8× 4.6k 0.5× 5.0k 0.8× 1.1k 0.3× 1.2k 0.3× 70 39.8k
Børge G. Nordestgaard Denmark 120 16.7k 1.3× 18.8k 2.1× 27.1k 4.3× 1.1k 0.3× 1.3k 0.3× 953 65.2k
Heiner C. Bucher Switzerland 60 2.0k 0.2× 1.2k 0.1× 3.4k 0.5× 2.8k 0.6× 1.3k 0.3× 253 15.0k
John W. Kusek United States 93 13.0k 1.0× 6.7k 0.7× 9.2k 1.5× 1.2k 0.3× 1.2k 0.3× 368 60.3k

Countries citing papers authored by James D. Neaton

Since Specialization
Citations

This map shows the geographic impact of James D. Neaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Neaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Neaton more than expected).

Fields of papers citing papers by James D. Neaton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James D. Neaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Neaton. The network helps show where James D. Neaton may publish in the future.

Co-authorship network of co-authors of James D. Neaton

This figure shows the co-authorship network connecting the top 25 collaborators of James D. Neaton. A scholar is included among the top collaborators of James D. Neaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James D. Neaton. James D. Neaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vanderven, Hillary A., Deborah Wentworth, Win Min Han, et al.. (2023). Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza. JCI Insight. 8(14). 5 indexed citations
2.
Safo, Sandra E., Jason V. Baker, Cavan Reilly, et al.. (2023). Derivation of a Protein Risk Score for Cardiovascular Disease Among a Multiracial and Multiethnic HIV+ Cohort. Journal of the American Heart Association. 12(13). e027273–e027273. 2 indexed citations
3.
Blumberg, Emily A., Gary Collins, Jo‐Anne H. Young, et al.. (2021). Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study. Transplant Infectious Disease. 24(1). 4 indexed citations
4.
Cunningham, Jonathan W., João Pedro Ferreira, Hsiaowei Deng, et al.. (2020). Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial. JACC Heart Failure. 8(5). 359–368. 10 indexed citations
5.
Phillips, Patrick, Carole D. Mitnick, James D. Neaton, et al.. (2019). Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape. PLoS Medicine. 16(3). e1002767–e1002767. 15 indexed citations
6.
Vock, David M., Abdel Babiker, John H. Powers, et al.. (2019). Comparison of an ordinal endpoint to time-to-event, longitudinal, and binary endpoints for use in evaluating treatments for severe influenza requiring hospitalization. Contemporary Clinical Trials Communications. 15. 100401–100401. 13 indexed citations
7.
Greenberg, Barry, Stefan D. Anker, William M. Byra, et al.. (2018). Effects of Rivaroxaban on Thrombotic Events in Heart Failure Patients With Coronary Disease and Sinus Rhythm. Circulation. 138(25). 1 indexed citations
8.
Molina, Jean‐Michel, Birgit Grund, Fred M. Gordin, et al.. (2018). Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial. The Lancet HIV. 5(4). e172–e180. 23 indexed citations
9.
Sharma, Shweta, Giuseppe Tambussi, Rika Draenert, et al.. (2018). Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial. AIDS and Behavior. 22(7). 2277–2283. 3 indexed citations
10.
Cobb, Laura K., Cheryl A.M. Anderson, Paul Elliott, et al.. (2014). Methodological Issues in Cohort Studies That Relate Sodium Intake to Cardiovascular Disease Outcomes. Circulation. 129(10). 1173–1186. 194 indexed citations
11.
Baker, Jason V., Kathleen E. Brummel‐Ziedins, Jacqueline Neuhaus, et al.. (2013). HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation. Journal of the American Heart Association. 2(4). e000264–e000264. 59 indexed citations
12.
Kiernan, Michael S., Deborah Wentworth, Gary S. Francis, et al.. (2012). Predicting Adverse Events During Angiotensin Receptor Blocker Treatment in Heart Failure: Results from the HEAAL Trial. European Journal of Heart Failure. 14(12). 1401–1409. 25 indexed citations
13.
Sandler, Netanya G., Handan Wand, Annelys Roque, et al.. (2011). Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection. The Journal of Infectious Diseases. 203(6). 780–790. 856 indexed citations breakdown →
14.
Konstam, Marvin A., Philip A. Poole‐Wilson, Kenneth Dickstein, et al.. (2008). Design of the Heart Failure Endpoint Evaluation of AII-Antagonist Losartan (HEAAL) Study in Patients Intolerant to ACE-Inhibitor. European Journal of Heart Failure. 10(9). 899–906. 12 indexed citations
15.
Kuller, Lewis H., Russell P. Tracy, Waldo Belloso, et al.. (2008). Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection. PLoS Medicine. 5(10). e203–e203. 1231 indexed citations breakdown →
16.
Coughlin, Steven S., James D. Neaton, Bryan Randall, & Anjana Sengupta. (1997). Predictors of mortality from kidney cancer in 332,547 men screened for the Multiple Risk Factor Intervention Trial. Cancer. 79(11). 2171–2177. 39 indexed citations
17.
18.
Stamler, Jeremiah, Ronald J. Prineas, James D. Neaton, et al.. (1987). Background and design of the new U.S. trial on diet and drug treatment of “mild” hypertension (TOMHS). The American Journal of Cardiology. 59(14). G51–G60. 67 indexed citations
19.
Rautaharju, Pentti M., Ronald J. Prineas, Curt D. Furberg, et al.. (1986). Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple risk factor intervention trial experience. Journal of the American College of Cardiology. 8(1). 1–10. 103 indexed citations
20.
Grimm, Richard H., et al.. (1985). Beneficial effects from systematic dosage reduction of the diuretic, chlorthalidone: A randomized study within a clinical trial. American Heart Journal. 109(4). 858–864. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael G. Shlipak Breakdown of academic impact, for papers by Alan S. Go Breakdown of academic impact, for papers by James B. Meigs Breakdown of academic impact, for papers by Patrick E. McBride Breakdown of academic impact, for papers by Alastair J.J. Wood Breakdown of academic impact, for papers by Neil J. Stone Breakdown of academic impact, for papers by Lesley A. Stevens Breakdown of academic impact, for papers by Børge G. Nordestgaard Breakdown of academic impact, for papers by Heiner C. Bucher Breakdown of academic impact, for papers by John W. Kusek
Rankless by CCL
2026